Catalyst
Slingshot members are tracking this event:
Aerie's (AERI) NDA filing for Rhopressa in Lowering Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension Q3 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AERI |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 06, 2016
Occurred Source:
http://investors.aeriepharma.com/releasedetail.cfm?ReleaseID=987974
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nda, Glaucoma, Rhopressa, Eye Disease, Rocket 2 Phase 3, Rocket 4
